Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07607158 · ClinicalTrials.gov registry record · NA

Influence of the Gut Microbiome on Blueberry Polyphenol Metabolites

A NA study, sponsored by Colorado State University.

Recruiting
Registry status
NA
Development phase
125
Enrollment target

NCT07607158 is a NA study that is actively recruiting participants, run by Colorado State University. The registered enrollment target is 125 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07607158, a NA study, is actively recruiting participants, sponsored by Colorado State University.

RECRUITING
Registry status
NA
Development phase
125 participants
Enrollment target

Study Summary

The objective of this study is to determine whether inter-individual differences in the gut microbiome influence exposure to blueberry polyphenol metabolites. We will use pharmacokinetics of blueberry polyphenols after an acute blueberry exposure to group individuals into "metabotypes", groups of individuals based on similarity in their metabolite profiles. We will then use multi-omic approaches to determine whether the gut microbiome predicts an individual's metabotype.

Interventions

  • OTHER Freeze-dried blueberry powder beverage

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2026-01-27
Est. Completion 2028-01-01
Phase NA

Sponsor

Colorado State University

94 total trials

What the Registry Record Tells You About NCT07607158

The ClinicalTrials.gov registry entry for NCT07607158 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colorado State University, which has 94 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Freeze-dried blueberry powder beverage is the first listed.

NCT07607158 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07607158 about?

NCT07607158 is a clinical study titled "Influence of the Gut Microbiome on Blueberry Polyphenol Metabolites". The objective of this study is to determine whether inter-individual differences in the gut microbiome influence exposure to blueberry polyphenol metabolites. We will use pharmacokinetics of blueberry polyphenols after an acute blueberry exposure to group individuals into "metabotypes", groups of in...

What is the current status of trial NCT07607158?

This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2026-01-27. Estimated completion is 2028-01-01.

What interventions are being tested in trial NCT07607158?

The interventions under investigation include: Freeze-dried blueberry powder beverage (OTHER).

Who is sponsoring clinical trial NCT07607158?

This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.